Literature DB >> 7056262

Carbon-13 nuclear-magnetic-resonance studies of glucose catabolism by Trypanosoma brucei gambiense.

N E Mackenzie, J E Hall, J R Seed, A I Scott.   

Abstract

13C Nuclear magnetic resonance studies have been performed in vivo on Trypanosoma brucei gambiense. The glycolytic pathway has been observed using specifically labelled 13C-enriched glucose and it has been ascertained that there is, under anaerobic conditions, predominant incorporation of C-1 of glucose into glycerol while there is complete randomisation of C-6 of glucose into glycerol and pyruvate. These observations cannot be reconciled by the Embden-Meyerhof glycolytic pathway, purportedly the mechanism by which glucose is catabolised in these organisms, and an alternative pathway must exist. Comparison of whole-cell and acid-lysate 13C nuclear magnetic resonance spectra concludes that pyruvate may be initially formed bound to a macromolecular species. Also, alanine is found to be a major end product of glucose catabolism.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7056262     DOI: 10.1111/j.1432-1033.1982.tb05836.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  3 in total

1.  Products of Leishmania braziliensis glucose catabolism: release of D-lactate and, under anaerobic conditions, glycerol.

Authors:  T N Darling; D G Davis; R E London; J J Blum
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

2.  Dynamic modelling under uncertainty: the case of Trypanosoma brucei energy metabolism.

Authors:  Fiona Achcar; Eduard J Kerkhoven; Barbara M Bakker; Michael P Barrett; Rainer Breitling
Journal:  PLoS Comput Biol       Date:  2012-01-19       Impact factor: 4.475

3.  Probing the metabolic network in bloodstream-form Trypanosoma brucei using untargeted metabolomics with stable isotope labelled glucose.

Authors:  Darren J Creek; Muriel Mazet; Fiona Achcar; Jana Anderson; Dong-Hyun Kim; Ruwida Kamour; Pauline Morand; Yoann Millerioux; Marc Biran; Eduard J Kerkhoven; Achuthanunni Chokkathukalam; Stefan K Weidt; Karl E V Burgess; Rainer Breitling; David G Watson; Frédéric Bringaud; Michael P Barrett
Journal:  PLoS Pathog       Date:  2015-03-16       Impact factor: 6.823

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.